Genetic analysis of second primary lung cancers in patients surviving small cell lung cancer.

We performed genetic analysis on 12 second primary non-small cell lung cancers in patients surviving small cell lung cancer to assess the potential contribution of smoking to the development of these tumors. Mutations of TP53 were found in three (25%) tumors, KRAS2 in three (25%) tumors, and CDKN2 in two (18%) tumors. Four (50%) mutations (one each in TP53 and CDKN2 and two in KRAS2) were G:C to T:A transversions on the coding strand, a mutation accounting for approximately one-third of mutations in smoking-related tumors but uncommonly found in lung cancers not associated with smoking. The genetic changes in these second lung cancers are more representative of smoking-associated malignancies than lung cancers arising in patients occupationally exposed to irradiation and atomic bomb survivors.

[1]  M. Kelley,et al.  Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. , 1995, Oncogene.

[2]  M. Kelley,et al.  TP53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract , 1995, International journal of cancer.

[3]  R. Metcalf,et al.  p53 mutations in lung cancers from Japanese mustard gas workers. , 1994, Carcinogenesis.

[4]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[5]  S. Venitt,et al.  Radon, mycotoxins, p53, and uranium mining , 1994, The Lancet.

[6]  Marshall W. Anderson,et al.  53 mutation hotspot in radon-associated lung cancer , 1994, The Lancet.

[7]  J. Taylor,et al.  p53 mutation hotspot in radon-associated lung cancer , 1994, The Lancet.

[8]  Y. Takeshima,et al.  p53 mutations in lung cancers from non-smoking atomic-bomb survivors , 1993, The Lancet.

[9]  W. Hong,et al.  Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. , 1993, Cancer research.

[10]  S. Hirohashi,et al.  Application of the p53 Gene Mutation Pattern for Differential Diagnosis of Primary Versus Metastatic Lung Carcinomas , 1993, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[11]  J P Pignon,et al.  A meta-analysis of thoracic radiotherapy for small-cell lung cancer. , 1992, The New England journal of medicine.

[12]  R. Metcalf,et al.  Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners , 1992, The Lancet.

[13]  D. Carbone,et al.  Polymorphism at codon 213 within the p53 gene. , 1991, Oncogene.